The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: UK MIDDAY BRIEFING: Unilever Kicks Off New Earnings Season

Tue, 21st Jan 2014 13:03

(An item published at 1259 GMT misstated the market prices. The correct version follows.)

LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant Unilever Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and cost cutting.

The company said it is facing increased competition in its still-weak developed markets, while growth has moderated in emerging markets, a reality that Chief Executive Paul Polman says the company now has to just "deal with". While its personal care brands, like Dove, are doing well, sales of its refreshment brands and some of its food brands, like its spreads, fell.

Warning that competition will remain fierce in 2014, Polman pledged to stay focused on raising margins, even though it will invest in re-invigorating its stalled food business.

Unilever was joined by the likes of SABMiller, PZ Cussons and digital media company Next Fifteen Communications Group in warning that recent currency moves were weighing on earnings.

Brewing giant SABMiller reported higher sales for its fiscal third quarter that met analysts' expectations, as volumes rose and it managed to raise prices. Growth continued to be driven by emerging markets like Africa, Latin America and China. However, "depreciation of key currencies against the US dollar will adversely impact reported results," it warned.

Unilever's 2013 operating profit came in at EUR7.51 billion, up 8% from EUR7.0 billion in 2012. However, it said the increase would have been 15% is currencies had stayed constant during the year.

Next Fifteen, meanwhile, said the current strength of sterling against both the US dollar and the Euro will hold back its revenues and profits, even though trading was off to a strong start in the financial year.

In economic news, British Chancellor of the Exchequer George Osborne will be eagerly awaiting the latest growth forecasts from the International Monetary Fund later Tuesday. The fund is widely reported to be about to raise its forecasts for UK growth more than for any other major economy.

The United Nations Tuesday predicted that the world economy will grow 3% this year and 3.3% in 2015, after growth of 2.1% in 2012.

Backing the growth forecasts, the International Energy Agency nudged up its global oil demand growth forecast for 2014, citing demand strength. It moved up its global oil demand forecast by 1.3 million barrels a day, after reporting stronger-than-expected demand in the fourth quarter of last year.

In the UK, the value of mortgages disbursed by UK banks remained broadly stable in December from the previous month, figures released by the Council for Mortgage Lenders revealed. The total value of mortgage lending was GBP17 billion in December, up 49% on the same month in 2012 and the highest for that month since December 2007.

Meanwhile, British manufacturing order growth during three months to January hit the highest since April 2011, survey data from the Confederation of British Industry showed Tuesday.

Elsewhere, The Thai government has declared a 60-day state of emergency in Bangkok and parts of nearby province, after almost 80 days of anti-government protests in the capital that have taken a more violent turn in recent days, media reports in the country say.

Protests in Ukraine capital Kiev also continued overnight, when hundreds of radical opposition supporters pelted police with Molotov cocktails and cobblestones. Opposition leader and former boxing champion Vitaly Klitschko warned protesters that the government was sending paid thugs to destabilise the situation.

Iran may be taking steps to limit its nuclear programme, but that doesn't mean it's in step with the majority of the international community on regional issues. UN Secretary General Ban Ki-moon has revoked his invitation for Tehran to attend Wednesday's Syrian peace conference, saying Iranian officials had failed to support the goals of the international talks.

--------

FTSE 100: Up 0.1% at 6,845.85
FTSE 250: Down 0.3% at 16,183.93
AIM ALL-SHARE: Down 0.1% at 881.32
GBP-USD: 1.6431
EUR-USD: 1.3529
GOLD: USD1,243.90 an ounce
OIL (Brent): USD107.71 a barrel

--------

KEY UK CORPORATE NEWS:

FTSE 100: IMI is proposing to return GBP620 million, or 200 pence a share, to shareholders from proceeds of the disposal of its Beverage Dispense and Merchandising division. Melrose Industries, meanwhile, said it plans to use part of the proceeds from FKI business disposals to return about GBP600 million to shareholders, after using some of the proceeds to pay down borrowings. GlaxoSmithKline's joint venture Viiv Healthcare Ltd has had its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission.

FTSE 250: African Barrick Gold has exceeded its initial 2013 gold production guidance and continued its cost cutting. Gold production of 641,931 ounces was 3% higher than in 2012 and significantly exceeded guidance of between 540,000 and 600,000 ounces. Its preliminary fourth quarter all-in sustaining cost was USD1,171 per ounce of gold sold, down 30% on the previous year and 8% on the previous quarter. Polymetal International produced 1.3 million ounces of gold equivalent in 2013, a 21% increase on the previous year and above its production guidance of 1.2 million ounces. Cairn Energy plans to drill nine wells in its 2014 exploration programme across a mix of different areas. John Wood Group has secured two major contract extensions in Africa worth USD250 million. Carphone Warehouse has reiterated its full-year guidance after it saw 3.1% like-for-like revenue growth in its fiscal third quarter and encouraging progress on its sales of 4G services. Like-for-like sales were up 5% in the UK. Marston's says trading in the financial year to date has been "encouraging", with profitability in line with expectations, boosted by good trading over the Christmas and New Year period. The brewer also said that it achieved like-for-like sales growth across is business estate. PZ Cussons said revenue for the half-year was up 4.1%, in line with management expectations, as it boosted its interim dividend to 2.53 pence per share. Restaurant Group has started searching for a replacement for Chief Executive Officer Andrew Page, who will retire in August. Intermediate Capital Group said it raised EUR1.1 billion of new third-party money in the third quarter, lifting nine-month gross inflows above the full previous year. Petra Diamonds has found an "exceptional" 29.6 carat blue diamond at its Cullinan mine in South Africa.

AIM: Rose Petroleum is a big gainer after it completed the previously announced acquisition of two fracking licences in Germany. The company said it has purchased the entire share capital of Parkyn Energy Holdings PLC, which owns 100% of the German licences through its subsidiary Parkyn Energy Germany Ltd, for EUR400,000. Pressure Technologies is doing well after its alternative energy division, Chesterfield BioGas, was awarded a GBP4.2 million contract to upgrade biogas supply equipment to the UK energy grid, and is also in advanced talks on potential further deals. IQE is another gainer as it said it expects to report 2013 revenue of at least GBP126.0 million, up 43% from GBP88.0 million in 2012. The company also expects Ebitda of at least GBP24.5 million, up 49% from GBP16.4 million in 2012, as it improved its operational efficiency. Touchstone Gold is a big faller after it warned that if it cannot find additional funding it will not be able to meet scheduled payments to vendors of its concession contracts. Touchstone also said it has managed to enter into an agreement to grant 6.5 million shares at a price of 0.932 pence per share by way of a private placement. Red Rock Resources is another faller after it raised GBP360,000 by placing 77 million shares at 0.47 pence each. The proceeds of the placing will be put towards repayments and working capital. Corero Network Security is down after the network security provider said it expects its Ebitda loss to widen for 2013.

--------

AFTERNOON WATCHLIST: US Redbook Index, IMF Global Growth Forecasts

--------

Wednesday's Key UK Corporate Events

JD Wetherspoon Trading statement
Optos Interim Management Statement
BHP Billiton December Quarter Production, Exploration, Development Report
Hochschild Mining Production Report
Land Securities Group Interim Management Statement
Noble Corporation Q4 Results
Sage Group Interim Management Statement
London Mining Production Report
Findel Interim Management Statement

-------

Wednesday's Key Economic Events

All Day World Economic Forum - Davos
03:00 Japan BoJ Interest Rate Decision
09:30 UK Bank of England Minutes
09:30 UK ILO Unemployment Rate
09:30 UK Public Sector Net Borrowing
12:00 US MBA Mortgage Applications

-------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.